Literature DB >> 23636061

Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.

Stephen J Griffiths1, Natalie E Riddell, Joanne Masters, Valentina Libri, Sian M Henson, Anne Wertheimer, Diana Wallace, Stuart Sims, Laura Rivino, Anis Larbi, David M Kemeny, Janko Nikolich-Zugich, Florian Kern, Paul Klenerman, Vince C Emery, Arne N Akbar.   

Abstract

The mechanisms regulating memory CD8(+) T cell function and homeostasis during aging are unclear. CD8(+) effector memory T cells that re-express CD45RA increase considerably in older humans and both aging and persistent CMV infection are independent factors in this process. We used MHC class I tetrameric complexes that were mutated in the CD8 binding domain to identify CMV-specific CD8(+) T cells with high Ag-binding avidity. In individuals who were HLA-A*0201, CD8(+) T cells that expressed CD45RA and were specific for the pp65 protein (NLVPMVATV epitope) had lower avidity than those that expressed CD45RO and demonstrated decreased cytokine secretion and cytolytic potential after specific activation. Furthermore, low avidity NLVPMVATV-specific CD8(+) T cells were significantly increased in older individuals. The stimulation of blood leukocytes with CMV lysate induced high levels of IFN-α that in turn induced IL-15 production. Moreover, the addition of IL-15 to CD45RA(-)CD45RO(+) CMV-specific CD8(+) T cells induced CD45RA expression while Ag activated cells remained CD45RO(+). This raises the possibility that non-specific cytokine-driven accumulation of CMV-specific CD8(+)CD45RA(+) T cells with lower Ag-binding avidity may exacerbate the effects of viral reactivation on skewing the T cell repertoire in CMV-infected individuals during aging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636061      PMCID: PMC3736312          DOI: 10.4049/jimmunol.1203267

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Authors:  Naeem Khan; Mark Cobbold; Joanne Cummerson; Paul A H Moss
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

Review 2.  Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes.

Authors:  S Prösch; W D Döcke; P Reinke; H D Volk; D H Krüger
Journal:  Intervirology       Date:  1999       Impact factor: 1.763

3.  Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow.

Authors:  Umaimainthan Palendira; Rosanna Chinn; Wajid Raza; Karen Piper; Guy Pratt; Lee Machado; Andrew Bell; Naeem Khan; Andrew D Hislop; Richard Steyn; Alan B Rickinson; Christopher D Buckley; Paul Moss
Journal:  Blood       Date:  2008-07-17       Impact factor: 22.113

4.  Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells.

Authors:  Dietmar Herndler-Brandstetter; Katja Landgraf; Brigitte Jenewein; Alexandar Tzankov; Regina Brunauer; Stefan Brunner; Walther Parson; Frank Kloss; Robert Gassner; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

5.  Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides.

Authors:  Y Tagaya; G Kurys; T A Thies; J M Losi; N Azimi; J A Hanover; R N Bamford; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 6.  Dynamics of T cell memory in human cytomegalovirus infection.

Authors:  Edward C P Waller; Elizabeth Day; J G Patrick Sissons; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

7.  Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense.

Authors:  Ilhem Messaoudi; Joël Lemaoult; Jose A Guevara-Patino; Beatrix M Metzner; Janko Nikolich-Zugich
Journal:  J Exp Med       Date:  2004-11-15       Impact factor: 14.307

8.  Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors.

Authors:  María Luisa Pita-Lopez; Inmaculada Gayoso; Olga DelaRosa; Javier G Casado; Corona Alonso; Elisa Muñoz-Gomariz; Raquel Tarazona; Rafael Solana
Journal:  Immun Ageing       Date:  2009-08-28       Impact factor: 6.400

Review 9.  T cell sensitivity and the outcome of viral infection.

Authors:  L J Walker; A K Sewell; P Klenerman
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

10.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Authors:  Sven Koch; Anis Larbi; Evelyna Derhovanessian; Dennis Ozcelik; Elissaveta Naumova; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-07-25       Impact factor: 6.400

View more
  36 in total

Review 1.  T-cell aging in rheumatoid arthritis.

Authors:  Cornelia M Weyand; Zhen Yang; Jörg J Goronzy
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

Review 2.  Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common.

Authors:  J Kennedy Amaral; Joshua B Bilsborrow; Robert T Schoen
Journal:  Am J Med       Date:  2019-11-06       Impact factor: 4.965

3.  Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects.

Authors:  Mazen Almehmadi; Brian F Flanagan; Naeem Khan; Suliman Alomar; Stephen E Christmas
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

5.  Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.

Authors:  Ester B M Remmerswaal; Paul L Klarenbeek; Nuno L Alves; Marieke E Doorenspleet; Barbera D C van Schaik; Rebecca E E Esveldt; Mirza M Idu; Ester M M van Leeuwen; Nelly van der Bom-Baylon; Antoine H C van Kampen; Sven D Koch; Hanspeter Pircher; Frederike J Bemelman; Anja Ten Brinke; Frank Baas; Ineke J M Ten Berge; Rene A W van Lier; Niek de Vries
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 6.  Aging of the immune system: Focus on inflammation and vaccination.

Authors:  Marcello Pinti; Victor Appay; Judith Campisi; Daniela Frasca; Tamas Fülöp; Delphine Sauce; Anis Larbi; Birgit Weinberger; Andrea Cossarizza
Journal:  Eur J Immunol       Date:  2016-10       Impact factor: 5.532

Review 7.  T cell responses to cytomegalovirus.

Authors:  Paul Klenerman; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2016-04-25       Impact factor: 53.106

8.  Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection.

Authors:  Kilian Schober; Florian Voit; Simon Grassmann; Thomas R Müller; Joel Eggert; Sebastian Jarosch; Bianca Weißbrich; Patrick Hoffmann; Lisa Borkner; Enzo Nio; Lorenzo Fanchi; Christopher R Clouser; Aditya Radhakrishnan; Lorenz Mihatsch; Philipp Lückemeier; Justin Leube; Georg Dössinger; Ludger Klein; Michael Neuenhahn; Jennifer D Oduro; Luka Cicin-Sain; Veit R Buchholz; Dirk H Busch
Journal:  Nat Immunol       Date:  2020-03-16       Impact factor: 25.606

9.  Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults.

Authors:  James E Turner; John P Campbell; Kate M Edwards; Lauren J Howarth; Graham Pawelec; Sarah Aldred; Paul Moss; Mark T Drayson; Victoria E Burns; Jos A Bosch
Journal:  Age (Dordr)       Date:  2013-07-12

10.  IFN-α inhibits telomerase in human CD8⁺ T cells by both hTERT downregulation and induction of p38 MAPK signaling.

Authors:  Alessio Lanna; Elias Coutavas; Lauretta Levati; Judith Seidel; Malcolm H A Rustin; Sian M Henson; Arne N Akbar; Ornella Franzese
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.